Professor of Medicine
University of Texas Health Sciences Center Leader
Breast Cancer Program at Mays Cancer Center
Bio
Dr. Kaklamani completed her medical training with honors at the University of Athens and completed her residency in internal medicine at Newton Wellesley Hospital in Boston. She completed her fellowship in hematology and oncology at Northwestern University and also received a Master of Science degree in clinical investigation from Northwestern University. Prior to joining the University of Texas Health Science Center San Antonio, she was head of the Translational Breast Program at Northwestern University and co-director of Northwestern’s cancer genetics program.
Dr. Kaklamani’s research interests include studying high-risk families and identifying genetic mutations that are associated with an increased risk for breast, colon and prostate cancer. Additionally, she is a clinical investigator with expertise in designing clinical trials with targeted agents.
As a Lynn Sage Scholar, Dr. Kaklamani studied the risk factors for weight gain in women who are newly diagnosed with breast cancer. Women diagnosed with breast cancer are susceptible to increased weight gain, which in turn, increases the chance of recurrence of the cancer. She has identified several genetic mutations related to obesity that increase the risk of breast cancer.
“The Lynn Sage Foundation has given me the support to examine the role of obesity related genes in breast cancer. This will help our breast cancer patients live longer and better lives, ” comments Dr. Kaklamani.
“The Lynn Sage Foundation has given me the support to examine the role of obesity related genes in breast cancer. This will help our breast cancer patients live longer and better lives”
Dr. Virginia Kaklamani
University of Texas Health Science Center San Antonio
Newly funded researchers pursuing high-risk, high-reward breast cancer studies in their first or second academic positions.
Past
Early Investigator
Abde Abukhdeir, PhD
The molecular variants that lead or contribute to drug resistance in breast cancer
Past
Early Investigator
Nan Chen, MD
Discovering novel biomarkers of therapy response and resistance in metastatic triple-negative breast cancer patients
Past
Early Investigator
Peiwen Chen, PhD
Targeting macrophage reprogramming in brain metastatic breast cancer
Why your gift matters
Your gift helps researchers test bold ideas, generate critical data, and take the first steps toward the next major advancement in breast cancer treatment and care.Together, we can accelerate discoveries that save lives.
